Ferox 2 ml Injection

About Ferox 2 ml 100 mg/2 ml Injection

Ferox 2 ml injection is made by Advanced Chemical Industries PLC and contains ferric carboxymaltose 100 mg/2 ml. It is a parenteral iron preparation given by a healthcare professional for iron deficiency anaemia in certain adults.

There are 15 brands of Ferric Carboxymaltose listed in Bangladesh. The lowest listed price is Ferium Injection 500 mg/10 ml at ৳ 700 per unit.

What is Ferox 2 ml 100 mg/2 ml Injection?

Ferox 2 ml is an injection from Advanced Chemical Industries PLC that contains ferric carboxymaltose 100 mg/2 ml. It belongs to a group of medicines called parenteral iron preparations. It is used in adults with iron deficiency anaemia who cannot tolerate iron tablets or do not respond well enough to them, and in adults with non-dialysis dependent chronic kidney disease. It is given by a healthcare professional, not by the patient at home. The doctor decides whether it is suitable and how it should be given.

Uses of Ferox 2 ml

Ferox 2 ml is used to treat iron deficiency anaemia in adults who have intolerance to oral iron or an unsatisfactory response to oral iron, and in adults with non-dialysis dependent chronic kidney disease. It helps replace iron stores in the body. Only a doctor can confirm whether this injection is appropriate for a particular person.

How to use Ferox 2 ml

Ferox 2 ml is given by a doctor or nurse as an intravenous injection or infusion in a healthcare setting. You should not inject it yourself. The doctor decides the dose and course, taking into account body weight and other factors. Tell the healthcare team about any allergies or previous reactions to iron medicines before you receive it.

Side effects of Ferox 2 ml

Side effects that may occur with Ferox 2 ml include nausea, vomiting, dizziness, headache, flushing, high or low blood pressure, rash, itching, hives, wheezing, constipation, a metallic taste, injection site discolouration, and changes in blood phosphorus or liver enzymes. Serious allergic reactions can happen. Seek urgent medical help if you develop breathing difficulty, swelling, severe dizziness, or collapse after receiving it.

Safety and precautions

Ferox 2 ml can cause serious hypersensitivity reactions, including life-threatening ones. It should be given only where staff and treatments for such reactions are immediately available, and you should be monitored during and after administration. Tell your doctor if you are allergic to any of its components. It is pregnancy category C, so ask your doctor whether it is suitable if you are pregnant, planning pregnancy, or breastfeeding. The doctor will decide if you need extra checks or should avoid it.

Frequently asked questions

What kind of medicine is Ferox 2 ml and what is it used for?

Ferox 2 ml is a parenteral iron preparation containing ferric carboxymaltose. It is used in adults for iron deficiency anaemia when oral iron is not tolerated or not effective enough, and in non-dialysis dependent chronic kidney disease. A doctor decides if it is suitable.

Which medicines may interact with Ferox 2 ml?

No drug interactions are known or well documented for ferric carboxymaltose. However, always tell your doctor and pharmacist about all medicines, supplements, and herbal products you take, so they can check whether Ferox 2 ml is appropriate for you.

What side effects should I watch for and when should I call the doctor?

Watch for nausea, vomiting, dizziness, headache, flushing, rash, itching, hives, wheezing, or changes in blood pressure. Call your doctor promptly if these occur. Seek emergency help right away for breathing difficulty, swelling of the face or throat, severe dizziness, or collapse, as these may be signs of a serious allergic reaction.

Who should ask a doctor before receiving Ferox 2 ml?

Anyone with a known allergy to any ingredient of Ferox 2 ml should ask a doctor first. Pregnant women, those planning pregnancy, and breastfeeding women should also speak to their doctor. The doctor will decide whether it is safe and appropriate for you.

Indications

Ferric Carboxymaltose is indicated for the treatment of iron deficiency anemia in adult patients-
  • Who have intolerance to oral iron or have had unsatisfactory response to oral iron
  • Who have non-dialysis dependent chronic kidney disease.

Pharmacology

Non-dextran, IV is a colloidal iron hydroxide in complex with carboxymaltose, a carbohydrate polymer that releases iron; replaces iron stores found in hemoglobin, myoglobin, and enzymes; works to transport oxygen via hemoglobin Macrophage engulf FCM from blood and control iron release. Transferrin saturates and, Iron into the liver, spleen and Bone marrow.

Dosage & Administration

For patients weighing 50 kg or more: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 750 mg for a total cumulative dose not to exceed 1500 mg of iron per course.

For patients weighing less than 50 kg: Give Ferric Carboxymaltose in two doses separated by at least 7 days. Give each dose as 15 mg/kg body weight for a total cumulative dose not to exceed 1500 mg of iron per course.

The dosage of Ferric Carboxymaltose is expressed in mg of elemental iron. Each mL of Ferric Carboxymaltose contains 50 mg of elemental iron. Ferric Carboxymaltose treatment may be repeated if iron deficiency anemia reoccurs.

Administer Ferric Carboxymaltose intravenously, either as an undiluted slow intravenous push or by infusion. When administering as a slow intravenous push, give at the rate of approximately 100 mg (2 mL) per minute. When administered via infusion, dilute up to 750 mg of iron in no more than 250 mL of sterile 0.9% sodium chloride injection, USP, such that the concentration of the infusion is not less than 2 mg of iron per mL and administer over at least 15 minutes.

When added to an infusion bag containing 0.9% Sodium Chloride Injection, USP, at concentrations ranging from 2 mg to 4 mg of iron per mL, Ferric Carboxymaltose solution is physically and chemically stable for 72 hours when stored at room temperature. To maintain stability, do not dilute to concentrations less than 2 mg iron/mL.

Inspect parenteral drug products visually for the absence of particulate matter and discoloration prior to administration. The product contains no preservatives. Each vial of Ferric Carboxymaltose is intended for single use only. Any unused drug remaining after injection must be discarded.

Avoid extravasation of Ferric Carboxymaltose since brown discoloration of the extravasation site may be long lasting. Monitor for extravasation. If extravasation occurs, discontinue the Ferric Carboxymaltose administration at that site.

Interaction

There are no known drug interactions and none well documented.

Contraindications

Hypersensitivity to any of its components.

Side Effects

Nausea, Hypertension, Flushing, Decreased blood phosphorus, Dizziness, Vomiting, Pruritus, Rash, Urticaria, Wheezing, Injection site discoloration, Headache, Increased alanine aminotransferase), Dysgeusia, Hypotension, Constipation, Serious anaphylactic/anaphylactoid reactions

Pregnancy & Lactation

Pregnancy Category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Precautions & Warnings

Hypersensitivity Reactions: Serious hypersensitivity reactions, including anaphylactic-type reactions, some of which have been life-threatening and fatal, have been reported in patients receiving Ferric carboxymaltose. Patients may present with shock, clinically significant hypotension, loss of consciousness, and/or collapse. Monitor patients for signs and symptoms of hypersensitivity during and after Ferric carboxymaltose administration for at least 30 minutes and until clinically stable following completion of the infusion. Only administer Ferric carboxymaltose when personnel and therapies are immediately available for the treatment of serious hypersensitivity reactions. Other serious or severe adverse reactions potentially associated with hypersensitivity which included, but not limited to, pruritus, rash, urticaria, wheezing, or hypotension may occur.

Hypertension: 
Transient elevations in systolic blood pressure, sometimes occurring with facial flushing, dizziness, or nausea were observed. These elevations generally occurred immediately after dosing and resolved within 30 minutes. Monitor patients for signs and symptoms of hypertension following each Ferric carboxymaltose administration.

Storage Conditions

Do not store above 30°C. Do not freeze.

Alternative brands of Ferric Carboxymaltose

Other brands with the same generic name, cheapest first.

See all 15 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.